BioPharm Asia, Inc. Comments on Current Status of Filing 2009 Annual Report on Form 10-K
4/26/2010 9:47:49 AM
SHENZHEN, China & LOS ANGELES--(BUSINESS WIRE)--BioPharm Asia Inc. (OTCBB: BFAR - News), a rapidly growing pharmaceutical company in China, today announced that it is preparing its Annual Report on Form 10-K for the year ended December 31, 2009. This filing has been delayed due to the change in the Company’s auditors, which occurred in late February, and the recent appointment of Wenzhong Qin as its Chief Financial Officer, which occurred on March 23, 2010.
Given that this time around, they have to file 10-k's for 3 years plus they are under no 15 day time limit, the delay may be excused. But if history were to repeat itself, which I'm convinced it will soon, we'll all be richer.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.